Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,889 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of the PPARG2 Pro12Ala Polymorphism on Associations of Physical Activity and Sedentary Time with Markers of Insulin Sensitivity in Those with an Elevated Risk of Type 2 Diabetes.
Yates T, Davies MJ, Henson J, Edwardson C, Webb D, Bodicoat DH, Webb M, Howard P, Cooper JA, Humphries SE, Khunti K, Talmud P. Yates T, et al. Among authors: webb m, webb d. PLoS One. 2015 May 14;10(5):e0124062. doi: 10.1371/journal.pone.0124062. eCollection 2015. PLoS One. 2015. PMID: 25974167 Free PMC article.
A randomized, open-label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes.
Webb DR, Htike ZZ, Swarbrick DJ, Brady EM, Gray LJ, Biglands J, Gulsin GS, Henson J, Khunti K, McCann GP, Waller HL, Webb MA, Sargeant JA, Yates T, Zaccardi F, Davies MJ. Webb DR, et al. Among authors: webb ma. Diabetes Obes Metab. 2020 Jul;22(7):1187-1196. doi: 10.1111/dom.14023. Epub 2020 Apr 1. Diabetes Obes Metab. 2020. PMID: 32157772 Free article. Clinical Trial.
Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity: Analyses from the LYDIA trial.
Ahmad E, Waller HL, Sargeant JA, Webb MA, Htike ZZ, McCann GP, Gulsin G, Khunti K, Yates T, Henson J, Davies MJ, Webb DR. Ahmad E, et al. Among authors: webb dr, webb ma. Diabetes Obes Metab. 2021 Jun;23(6):1409-1414. doi: 10.1111/dom.14343. Epub 2021 Feb 26. Diabetes Obes Metab. 2021. PMID: 33565691
1,889 results